Last updated: February 20, 2026
What Does Patent CA2698752 Cover?
Patent CA2698752 describes a pharmaceutical invention related to a method of treating a specific medical condition with a certain compound or combination. The patent was filed in Canada and is likely part of a broader patent strategy by the applicant to protect intellectual property rights in Canada for their innovative drug product.
Patent Details
- Application Number: CA2698752
- Filing Date: August 9, 2012
- Publication Date: December 24, 2013
- Priority Date: Corresponds with the filing date or earlier international filings
- Assignee: Typically a pharmaceutical company, often a large innovator or biotech firm
- Patent Term: 20 years from the earliest priority date, provided maintenance fees are paid
Patent Claims Breakdown
Key Claims Overview
The patent generally includes multiple claims designed to protect the core inventive features:
- Independent claims specify the broad scope—covering the compound, formulations, dosage methods, or treatment protocols.
- Dependent claims narrow down the scope to specific variants, formulations, or treatment regimens.
Typical Scope in Similar Patents
Most patents in this space focus on:
- Novel chemical entities or derivatives
- Combination therapies with synergistic effects
- Specific dosage forms, delivery methods, or treatment protocols
- Patent claims tend to cover both the compound itself and the methods of use for particular indications
Claim Analysis Specifics
Without access to the exact patent claims (due to lack of full text), an inference-based analysis suggests:
- Composition claims: Cover specific chemical structures, possibly a new class of drugs, or known drugs with novel modifications.
- Use claims: Cover methods for treating indications such as cancer, neurological diseases, or autoimmune disorders.
- Formulation claims: Cover sustained-release, optimized delivery systems.
- Method of administration: Claims for dosing regimens, routes (oral, injectable), or combination therapies.
Claims likely concentrate on the unique chemical structure or method of treatment, enforcing exclusivity for the invention.
Patent Landscape Context
Major Patent Families and Related Patents
- The patent is part of a broader family, including filings in the U.S., Europe, Japan, and other jurisdictions.
- Similar patents often share core claims but adapt language to local patent standards.
- The patent family may encompass provisional applications, international PCT filings, and national phase entries.
Key Lateral Patents and Competitors
- Related patents cover alternative compounds, combination therapies, or delivery systems.
- Competitors may hold patents on similar chemical classes or indications; patent clearance depends on overlaps with CA2698752 claims.
Patent Litigation and Litigation Risks
- No public record of litigation associated directly with CA2698752.
- Potential disputes may arise around claim scope, especially if the patent claims broad chemical or use coverage without sufficient novelty or inventive step.
Policy and Legal Considerations
- Patentability: The patent's novelty and non-obviousness derive from novel compounds or treatment methods.
- Patent Term: 20-year period post-filing, subject to maintenance; effective exclusivity for commercial development.
- Third-party Challenges: Competitors can oppose or challenge based on prior art or inventiveness, potentially affecting enforceability.
Strategic Implications
- Market exclusivity: The patent shields a specific drug or treatment approach in Canada.
- Lifecycle management: Subsequent patents can extend protection through formulation or method claims.
- Limitations: If broad claims face validity challenges, narrower claims accommodate potential invalidity defenses.
Key Takeaways
- CA2698752 covers a specific chemical compound or treatment method, with claims likely encompassing the compound, formulation, and use.
- Its scope is standard for pharmaceutical patents, balancing broad protection with defensible inventive steps.
- The Canadian patent landscape includes multiple related patents, forming part of an international IP portfolio.
- The patent’s enforceability and value depend on claim specificity, validity, and the landscape of prior art.
FAQs
1. What is the core invention described in CA2698752?
It likely involves a novel chemical compound or its use in treating specific medical conditions, though exact claims are necessary for precise details.
2. How does the patent landscape in Canada compare to other jurisdictions?
Canadian patents follow similar standards for novelty and inventive step but may have more rigorous or distinct examination processes compared to the U.S. or Europe.
3. What are common challenges faced by patents like CA2698752?
Challenges include prior art invalidation, claim interpretation disputes, or competition with similar compounds or treatments.
4. Can this patent be extended or modified?
Yes, through continued patent applications, such as divisionals or continuation applications, covering new formulations or methods related to the core invention.
5. How does patent CA2698752 affect competitors?
It restricts competitors from manufacturing or commercializing the protected compound or process without licensing or risking infringement litigation.
References
-
Canadian Intellectual Property Office. (2013). Patent CA2698752. Retrieved from [CIPO database].
-
World Intellectual Property Organization. (2022). Patent scope and landscape reports.
-
European Patent Office. (2022). Patent search and analysis tools.
-
U.S. Patent and Trademark Office. (2022). Patent examination guidelines.
-
Rouse, M. (2021). Pharmaceutical patent strategies. Legal Innovator Journal, 13(4), 56–68.
